Advertisement
Table of Contents

April 2020

Cover

Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks
Issue Image

In the first quarter of 2020, the emergence of COVID-19 disease and the infectious agent SARS-CoV-2 transitioned from a serious respiratory disease outbreak in Wuhan, China to a global pandemic of almost universal concern and risk to health. Public health authorities, health workers and researchers mobilized to prevent the spread of infection as far as was possible, care for those infected, and develop therapeutic and preventive approaches. However, the toll in mortality and ill health was great, and disruption at all levels of societies profound.

In this month's Editorial, the PLOS Medicine Editors discuss existing and future planning for infectious disease outbreaks—at national and global levels.

Image Credit: Alexandra_Koch, Pixabay

Editorial

Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks

The PLOS Medicine Editors

PLOS Medicine: published April 28, 2020 | https://doi.org/10.1371/journal.pmed.1003123

Perspective

Hepatitis B prevention: Can we learn from the response to HIV/AIDS?

Mirjam E. E. Kretzschmar, Marianne A. B. van der Sande

PLOS Medicine: published April 21, 2020 | https://doi.org/10.1371/journal.pmed.1003109

Related Articles

  1. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis

Guidelines and Guidance

CINeMA: An approach for assessing confidence in the results of a network meta-analysis

Adriani Nikolakopoulou, Julian P. T. Higgins, Theodoros Papakonstantinou, Anna Chaimani, Cinzia Del Giovane, Matthias Egger, Georgia Salanti

PLOS Medicine: published April 3, 2020 | https://doi.org/10.1371/journal.pmed.1003082

Research Articles

HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial

Sian Floyd, Kwame Shanaube, Blia Yang, Ab Schaap, Sam Griffith, Mwelwa Phiri, David Macleod, Rosa Sloot, Kalpana Sabapathy, Virginia Bond, Peter Bock, Helen Ayles, Sarah Fidler, Richard Hayes, the HPTN 071 (PopART) study team

PLOS Medicine: published April 2, 2020 | https://doi.org/10.1371/journal.pmed.1003067

Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study

Reza Yaesoubi, Ted Cohen, Katherine Hsu, Thomas L. Gift, Harrell Chesson, Joshua A. Salomon, Yonatan H. Grad

PLOS Medicine: published April 3, 2020 | https://doi.org/10.1371/journal.pmed.1003077

Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015–2016

Stephanie S. Chan, Andre R. Chappel, Karen E. Joynt Maddox, Karen W. Hoover, Ya-lin A. Huang, Weiming Zhu, Stacy M. Cohen, Pamela W. Klein, Nancy De Lew

PLOS Medicine: published April 10, 2020 | https://doi.org/10.1371/journal.pmed.1003072

Effectiveness of the Common Elements Treatment Approach (CETA) in reducing intimate partner violence and hazardous alcohol use in Zambia (VATU): A randomized controlled trial

Laura K. Murray, Jeremy C. Kane, Nancy Glass, Stephanie Skavenski van Wyk, Flor Melendez, Ravi Paul, Carla Kmett Danielson, Sarah M. Murray, John Mayeya, Francis Simenda, Paul Bolton

PLOS Medicine: published April 17, 2020 | https://doi.org/10.1371/journal.pmed.1003056

Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis

Anna L. McNaughton, José Lourenço, Phillip Armand Bester, Jolynne Mokaya, Sheila F. Lumley, Uri Obolski, Donall Forde, Tongai G. Maponga, Kenneth R. Katumba, Dominique Goedhals, Sunetra Gupta, Janet Seeley, Robert Newton, Ponsiano Ocama, Philippa C. Matthews

PLOS Medicine: published April 21, 2020 | https://doi.org/10.1371/journal.pmed.1003068

Related Articles

  1. Hepatitis B prevention: Can we learn from the response to HIV/AIDS?

Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial

Atsushi Tanaka, Isao Taguchi, Hiroki Teragawa, Nobukazu Ishizaka, Yumiko Kanzaki, Hirofumi Tomiyama, Masataka Sata, Akira Sezai, Kazuo Eguchi, Toru Kato, Shigeru Toyoda, Ryoichi Ishibashi, Kazuomi Kario, Tomoko Ishizu, Shinichiro Ueda, Koji Maemura, Yukihito Higashi, Hirotsugu Yamada, Mitsuru Ohishi, Kotaro Yokote, Toyoaki Murohara, Jun-ichi Oyama, Koichi Node, on behalf of the PRIZE study investigators

PLOS Medicine: published April 22, 2020 | https://doi.org/10.1371/journal.pmed.1003095

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies

Helen Jarvis, Dawn Craig, Robert Barker, Gemma Spiers, Daniel Stow, Quentin M. Anstee, Barbara Hanratty

PLOS Medicine: published April 30, 2020 | https://doi.org/10.1371/journal.pmed.1003100